nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabrafenib—LIMK1—Axon guidance—MMP2—osteoarthritis	0.00249	0.00249	CbGpPWpGaD
Dabrafenib—BRAF—Senescence and Autophagy in Cancer—IL1B—osteoarthritis	0.00244	0.00244	CbGpPWpGaD
Dabrafenib—RAF1—VEGFR2 mediated cell proliferation—IL6—osteoarthritis	0.00244	0.00244	CbGpPWpGaD
Dabrafenib—RAF1—Signalling to RAS—IL6—osteoarthritis	0.00244	0.00244	CbGpPWpGaD
Dabrafenib—RAF1—IGF1R signaling cascade—IGF1—osteoarthritis	0.00243	0.00243	CbGpPWpGaD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	0.00243	0.00243	CbGpPWpGaD
Dabrafenib—RAF1—IL-3 Signaling Pathway—TGFB1—osteoarthritis	0.00241	0.00241	CbGpPWpGaD
Dabrafenib—CYP2C8—Biological oxidations—GSTO1—osteoarthritis	0.00238	0.00238	CbGpPWpGaD
Dabrafenib—RAF1—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.00237	0.00237	CbGpPWpGaD
Dabrafenib—CYP2C8—Metapathway biotransformation—GSTO1—osteoarthritis	0.00234	0.00234	CbGpPWpGaD
Dabrafenib—RAF1—AGE/RAGE pathway—MMP9—osteoarthritis	0.00231	0.00231	CbGpPWpGaD
Dabrafenib—RAF1—Ceramide signaling pathway—TNF—osteoarthritis	0.00229	0.00229	CbGpPWpGaD
Dabrafenib—RAF1—TGF-beta Signaling Pathway—MMP1—osteoarthritis	0.00228	0.00228	CbGpPWpGaD
Dabrafenib—BRAF—Disease—FMOD—osteoarthritis	0.00226	0.00226	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00225	0.00225	CbGpPWpGaD
Dabrafenib—BRAF—Focal Adhesion—FN1—osteoarthritis	0.00225	0.00225	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—IL1A—osteoarthritis	0.00222	0.00222	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—LEP—osteoarthritis	0.00222	0.00222	CbGpPWpGaD
Dabrafenib—RAF1—Leptin signaling pathway—IL1B—osteoarthritis	0.00221	0.00221	CbGpPWpGaD
Dabrafenib—RAF1—Cardiac Hypertrophic Response—TGFB1—osteoarthritis	0.0022	0.0022	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—IGF1—osteoarthritis	0.00219	0.00219	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—COL9A2—osteoarthritis	0.00215	0.00215	CbGpPWpGaD
Dabrafenib—ABCB1—HIF-1-alpha transcription factor network—SMAD3—osteoarthritis	0.00212	0.00212	CbGpPWpGaD
Dabrafenib—BRAF—Corticotropin-releasing hormone—TGFB1—osteoarthritis	0.00211	0.00211	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—COL9A1—osteoarthritis	0.00209	0.00209	CbGpPWpGaD
Dabrafenib—RAF1—TGF-beta Signaling Pathway—FN1—osteoarthritis	0.00208	0.00208	CbGpPWpGaD
Dabrafenib—RAF1—TWEAK Signaling Pathway—IL6—osteoarthritis	0.00206	0.00206	CbGpPWpGaD
Dabrafenib—RAF1—Cardiac Hypertrophic Response—TNF—osteoarthritis	0.00206	0.00206	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—IL1RN—osteoarthritis	0.00205	0.00205	CbGpPWpGaD
Dabrafenib—RAF1—FCERI mediated MAPK activation—IL6—osteoarthritis	0.00202	0.00202	CbGpPWpGaD
Dabrafenib—BRAF—Disease—IHH—osteoarthritis	0.00201	0.00201	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—CRP—osteoarthritis	0.002	0.002	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—HSPA5—osteoarthritis	0.00199	0.00199	CbGpPWpGaD
Dabrafenib—RAF1—Signalling to ERKs—IL6—osteoarthritis	0.00198	0.00198	CbGpPWpGaD
Dabrafenib—RAF1—FRS2-mediated cascade—IL6—osteoarthritis	0.00198	0.00198	CbGpPWpGaD
Dabrafenib—BRAF—Focal Adhesion—IGF1—osteoarthritis	0.00197	0.00197	CbGpPWpGaD
Dabrafenib—RAF1—Corticotropin-releasing hormone—CXCL8—osteoarthritis	0.00196	0.00196	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL1RN—osteoarthritis	0.00194	0.00194	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—osteoarthritis	0.00193	0.00193	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—IL1A—osteoarthritis	0.00192	0.00192	CbGpPWpGaD
Dabrafenib—RAF1—TCR Signaling Pathway—IL1B—osteoarthritis	0.00191	0.00191	CbGpPWpGaD
Dabrafenib—BRAF—Senescence and Autophagy in Cancer—TGFB1—osteoarthritis	0.0019	0.0019	CbGpPWpGaD
Dabrafenib—RAF1—Regulation of Actin Cytoskeleton—FN1—osteoarthritis	0.00189	0.00189	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—ESR1—osteoarthritis	0.00188	0.00188	CbGpPWpGaD
Dabrafenib—RAF1—Interleukin-2 signaling—IL6—osteoarthritis	0.00188	0.00188	CbGpPWpGaD
Dabrafenib—LIMK1—Axon guidance—MMP9—osteoarthritis	0.00187	0.00187	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—FMOD—osteoarthritis	0.00183	0.00183	CbGpPWpGaD
Dabrafenib—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoarthritis	0.00181	0.00181	CbGpPWpGaD
Dabrafenib—CYP2C8—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.00178	0.00178	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling in naïve CD8+ T cells—TNF—osteoarthritis	0.00178	0.00178	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—MMP2—osteoarthritis	0.00177	0.00177	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—CXCL8—osteoarthritis	0.00176	0.00176	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—IL1B—osteoarthritis	0.00169	0.00169	CbGpPWpGaD
Dabrafenib—BRAF—MAPK Signaling Pathway—IL1B—osteoarthritis	0.00168	0.00168	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by Interleukins—IL1B—osteoarthritis	0.00165	0.00165	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—MCF2L—osteoarthritis	0.00165	0.00165	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—IHH—osteoarthritis	0.00165	0.00165	CbGpPWpGaD
Dabrafenib—RAF1—SHP2 signaling—IL6—osteoarthritis	0.00159	0.00159	CbGpPWpGaD
Dabrafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—osteoarthritis	0.00157	0.00157	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.00157	0.00157	CbGpPWpGaD
Dabrafenib—RAF1—Disease—FMOD—osteoarthritis	0.00156	0.00156	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—FN1—osteoarthritis	0.00155	0.00155	CbGpPWpGaD
Dabrafenib—BRAF—Disease—TGFBI—osteoarthritis	0.0015	0.0015	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PTGES—osteoarthritis	0.00149	0.00149	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—CTSK—osteoarthritis	0.00149	0.00149	CbGpPWpGaD
Dabrafenib—RAF1—TCR Signaling Pathway—TGFB1—osteoarthritis	0.00148	0.00148	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—IL1A—osteoarthritis	0.00148	0.00148	CbGpPWpGaD
Dabrafenib—RAF1—MicroRNAs in cardiomyocyte hypertrophy—TNF—osteoarthritis	0.00146	0.00146	CbGpPWpGaD
Dabrafenib—RAF1—Corticotropin-releasing hormone—TGFB1—osteoarthritis	0.00146	0.00146	CbGpPWpGaD
Dabrafenib—BRAF—Senescence and Autophagy in Cancer—IL6—osteoarthritis	0.00143	0.00143	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—CTSK—osteoarthritis	0.00143	0.00143	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MCF2L—osteoarthritis	0.00141	0.00141	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IHH—osteoarthritis	0.00141	0.00141	CbGpPWpGaD
Dabrafenib—RAF1—NCAM signaling for neurite out-growth—IL6—osteoarthritis	0.0014	0.0014	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL1A—osteoarthritis	0.00139	0.00139	CbGpPWpGaD
Dabrafenib—RAF1—Disease—IHH—osteoarthritis	0.00139	0.00139	CbGpPWpGaD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—FN1—osteoarthritis	0.00138	0.00138	CbGpPWpGaD
Dabrafenib—RAF1—TNF alpha Signaling Pathway—TNF—osteoarthritis	0.00136	0.00136	CbGpPWpGaD
Dabrafenib—RAF1—Focal Adhesion—IGF1—osteoarthritis	0.00136	0.00136	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.00136	0.00136	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—MMP9—osteoarthritis	0.00133	0.00133	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—HSPA5—osteoarthritis	0.00131	0.00131	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—TGFB1—osteoarthritis	0.00131	0.00131	CbGpPWpGaD
Dabrafenib—BRAF—MAPK Signaling Pathway—TGFB1—osteoarthritis	0.0013	0.0013	CbGpPWpGaD
Dabrafenib—BRAF—Disease—GSTO1—osteoarthritis	0.0013	0.0013	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.0013	0.0013	CbGpPWpGaD
Dabrafenib—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	0.00128	0.00128	CbGpPWpGaD
Dabrafenib—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	0.00126	0.00126	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—MMP9—osteoarthritis	0.00126	0.00126	CbGpPWpGaD
Dabrafenib—BRAF—Disease—BGN—osteoarthritis	0.00126	0.00126	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—TIMP1—osteoarthritis	0.00125	0.00125	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—FMOD—osteoarthritis	0.00123	0.00123	CbGpPWpGaD
Dabrafenib—BRAF—MAPK Signaling Pathway—TNF—osteoarthritis	0.00122	0.00122	CbGpPWpGaD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	0.00121	0.00121	CbGpPWpGaD
Dabrafenib—RAF1—IRS-mediated signalling—IL6—osteoarthritis	0.00117	0.00117	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—CRP—osteoarthritis	0.00117	0.00117	CbGpPWpGaD
Dabrafenib—LIMK1—Axon guidance—IL6—osteoarthritis	0.00116	0.00116	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—IL1B—osteoarthritis	0.00116	0.00116	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—FMOD—osteoarthritis	0.00114	0.00114	CbGpPWpGaD
Dabrafenib—RAF1—IRS-related events—IL6—osteoarthritis	0.00114	0.00114	CbGpPWpGaD
Dabrafenib—RAF1—Adaptive Immune System—HSPA5—osteoarthritis	0.00114	0.00114	CbGpPWpGaD
Dabrafenib—RAF1—IRS-related events triggered by IGF1R—IL6—osteoarthritis	0.00113	0.00113	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.00112	0.00112	CbGpPWpGaD
Dabrafenib—RAF1—TCR Signaling Pathway—IL6—osteoarthritis	0.00112	0.00112	CbGpPWpGaD
Dabrafenib—RAF1—TNF alpha Signaling Pathway—IL6—osteoarthritis	0.0011	0.0011	CbGpPWpGaD
Dabrafenib—RAF1—Insulin receptor signalling cascade—IL6—osteoarthritis	0.0011	0.0011	CbGpPWpGaD
Dabrafenib—RAF1—IGF1R signaling cascade—IL6—osteoarthritis	0.0011	0.0011	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—TGFB1—osteoarthritis	0.0011	0.0011	CbGpPWpGaD
Dabrafenib—RAF1—TGF-beta Signaling Pathway—TGFB1—osteoarthritis	0.00109	0.00109	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—GSTO1—osteoarthritis	0.00105	0.00105	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—CXCL8—osteoarthritis	0.00104	0.00104	CbGpPWpGaD
Dabrafenib—RAF1—Disease—TGFBI—osteoarthritis	0.00104	0.00104	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—COL9A2—osteoarthritis	0.00103	0.00103	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—TNF—osteoarthritis	0.00103	0.00103	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—BGN—osteoarthritis	0.00102	0.00102	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR—IL6—osteoarthritis	0.00101	0.00101	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PTGES—osteoarthritis	0.001	0.001	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—COL9A1—osteoarthritis	0.001	0.001	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—IL1B—osteoarthritis	0.001	0.001	CbGpPWpGaD
Dabrafenib—RAF1—Senescence and Autophagy in Cancer—IL6—osteoarthritis	0.000989	0.000989	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MCF2L—osteoarthritis	0.000975	0.000975	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IHH—osteoarthritis	0.000975	0.000975	CbGpPWpGaD
Dabrafenib—RAF1—VEGFA-VEGFR2 Pathway—IL6—osteoarthritis	0.000974	0.000974	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by Interleukins—IL6—osteoarthritis	0.000967	0.000967	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by FGFR in disease—IL6—osteoarthritis	0.000941	0.000941	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PTGES—osteoarthritis	0.00093	0.00093	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by VEGF—IL6—osteoarthritis	0.000919	0.000919	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by Insulin receptor—IL6—osteoarthritis	0.000913	0.000913	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—TGFB1—osteoarthritis	0.000901	0.000901	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—SMAD3—osteoarthritis	0.000898	0.000898	CbGpPWpGaD
Dabrafenib—RAF1—Disease—GSTO1—osteoarthritis	0.000897	0.000897	CbGpPWpGaD
Dabrafenib—RAF1—Disease—BGN—osteoarthritis	0.000869	0.000869	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CAMK2B—osteoarthritis	0.000866	0.000866	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CTSK—osteoarthritis	0.000866	0.000866	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—MMP2—osteoarthritis	0.00086	0.00086	CbGpPWpGaD
Dabrafenib—RAF1—MAPK Signaling Pathway—TNF—osteoarthritis	0.000841	0.000841	CbGpPWpGaD
Dabrafenib—BRAF—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000833	0.000833	CbGpPWpGaD
Dabrafenib—LIMK1—Developmental Biology—IL6—osteoarthritis	0.000828	0.000828	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000813	0.000813	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by SCF-KIT—IL6—osteoarthritis	0.000781	0.000781	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—MMP1—osteoarthritis	0.000778	0.000778	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—TGFB1—osteoarthritis	0.000777	0.000777	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—IL1B—osteoarthritis	0.00077	0.00077	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—LEP—osteoarthritis	0.000767	0.000767	CbGpPWpGaD
Dabrafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000759	0.000759	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signaling of activated FGFR—IL6—osteoarthritis	0.000747	0.000747	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000739	0.000739	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB4—IL6—osteoarthritis	0.000735	0.000735	CbGpPWpGaD
Dabrafenib—LIMK1—Innate Immune System—IL6—osteoarthritis	0.000731	0.000731	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL1B—osteoarthritis	0.000727	0.000727	CbGpPWpGaD
Dabrafenib—ABCB1—Allograft Rejection—TNF—osteoarthritis	0.000725	0.000725	CbGpPWpGaD
Dabrafenib—RAF1—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000723	0.000723	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—COL9A2—osteoarthritis	0.000715	0.000715	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—FN1—osteoarthritis	0.00071	0.00071	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—FMOD—osteoarthritis	0.000708	0.000708	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—GSTO1—osteoarthritis	0.000707	0.000707	CbGpPWpGaD
Dabrafenib—RAF1—Downstream signal transduction—IL6—osteoarthritis	0.000702	0.000702	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR—IL6—osteoarthritis	0.000699	0.000699	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by ERBB2—IL6—osteoarthritis	0.000695	0.000695	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—COL9A1—osteoarthritis	0.000694	0.000694	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—CRP—osteoarthritis	0.000692	0.000692	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 signaling—IL6—osteoarthritis	0.000692	0.000692	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—HSPA5—osteoarthritis	0.000689	0.000689	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—BMP2—osteoarthritis	0.000688	0.000688	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—BGN—osteoarthritis	0.000685	0.000685	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL1RN—osteoarthritis	0.00067	0.00067	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000658	0.000658	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—GSTO1—osteoarthritis	0.000655	0.000655	CbGpPWpGaD
Dabrafenib—RAF1—DAP12 interactions—IL6—osteoarthritis	0.000651	0.000651	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by FGFR in disease—IL6—osteoarthritis	0.000651	0.000651	CbGpPWpGaD
Dabrafenib—RAF1—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000651	0.000651	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—MMP9—osteoarthritis	0.000646	0.000646	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR—IL6—osteoarthritis	0.000645	0.000645	CbGpPWpGaD
Dabrafenib—BRAF—Signaling by NGF—IL6—osteoarthritis	0.000641	0.000641	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by EGFR in Cancer—IL6—osteoarthritis	0.00064	0.00064	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000639	0.000639	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by PDGF—IL6—osteoarthritis	0.000637	0.000637	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—BGN—osteoarthritis	0.000634	0.000634	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—IGF1—osteoarthritis	0.000622	0.000622	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—FMOD—osteoarthritis	0.000617	0.000617	CbGpPWpGaD
Dabrafenib—BRAF—Disease—SMAD3—osteoarthritis	0.000616	0.000616	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—MMP2—osteoarthritis	0.000614	0.000614	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PTGES—osteoarthritis	0.000577	0.000577	CbGpPWpGaD
Dabrafenib—RAF1—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	0.000577	0.000577	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—MMP3—osteoarthritis	0.000558	0.000558	CbGpPWpGaD
Dabrafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	0.000557	0.000557	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.00053	0.00053	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PTGES—osteoarthritis	0.000503	0.000503	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL1A—osteoarthritis	0.000482	0.000482	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MMP3—osteoarthritis	0.000477	0.000477	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—BMP2—osteoarthritis	0.000476	0.000476	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—MMP9—osteoarthritis	0.000461	0.000461	CbGpPWpGaD
Dabrafenib—RAF1—Cytokine Signaling in Immune system—IL6—osteoarthritis	0.000451	0.000451	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by NGF—IL6—osteoarthritis	0.000444	0.000444	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000442	0.000442	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—SMAD3—osteoarthritis	0.000432	0.000432	CbGpPWpGaD
Dabrafenib—RAF1—Disease—SMAD3—osteoarthritis	0.000426	0.000426	CbGpPWpGaD
Dabrafenib—LIMK1—Immune System—IL6—osteoarthritis	0.000426	0.000426	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—GSTO1—osteoarthritis	0.000407	0.000407	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—CRP—osteoarthritis	0.000403	0.000403	CbGpPWpGaD
Dabrafenib—RAF1—Axon guidance—IL6—osteoarthritis	0.000401	0.000401	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—BGN—osteoarthritis	0.000394	0.000394	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000383	0.000383	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—TGFB1—osteoarthritis	0.00038	0.00038	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—FMOD—osteoarthritis	0.00038	0.00038	CbGpPWpGaD
Dabrafenib—RAF1—Hemostasis—TGFB1—osteoarthritis	0.000373	0.000373	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—LEP—osteoarthritis	0.000369	0.000369	CbGpPWpGaD
Dabrafenib—BRAF—Disease—PTGS2—osteoarthritis	0.000361	0.000361	CbGpPWpGaD
Dabrafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000358	0.000358	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—TNF—osteoarthritis	0.000355	0.000355	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—GSTO1—osteoarthritis	0.000354	0.000354	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—ESR1—osteoarthritis	0.000352	0.000352	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—FN1—osteoarthritis	0.000348	0.000348	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—BGN—osteoarthritis	0.000343	0.000343	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MMP3—osteoarthritis	0.00033	0.00033	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTGES—osteoarthritis	0.00031	0.00031	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IGF1—osteoarthritis	0.000305	0.000305	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—SMAD3—osteoarthritis	0.000299	0.000299	CbGpPWpGaD
Dabrafenib—SLCO1B3—Metabolism—PTGS2—osteoarthritis	0.000293	0.000293	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—CXCL8—osteoarthritis	0.000287	0.000287	CbGpPWpGaD
Dabrafenib—RAF1—Developmental Biology—IL6—osteoarthritis	0.000286	0.000286	CbGpPWpGaD
Dabrafenib—BRAF—Disease—TGFB1—osteoarthritis	0.000261	0.000261	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—LEP—osteoarthritis	0.000255	0.000255	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000254	0.000254	CbGpPWpGaD
Dabrafenib—RAF1—Innate Immune System—IL6—osteoarthritis	0.000253	0.000253	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL1B—osteoarthritis	0.000252	0.000252	CbGpPWpGaD
Dabrafenib—RAF1—Disease—PTGS2—osteoarthritis	0.00025	0.00025	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—CXCL8—osteoarthritis	0.000245	0.000245	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—ESR1—osteoarthritis	0.000244	0.000244	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—FN1—osteoarthritis	0.000241	0.000241	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—MMP9—osteoarthritis	0.000222	0.000222	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—GSTO1—osteoarthritis	0.000218	0.000218	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—BGN—osteoarthritis	0.000211	0.000211	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IGF1—osteoarthritis	0.000211	0.000211	CbGpPWpGaD
Dabrafenib—SLCO1B1—Metabolism—PTGS2—osteoarthritis	0.000197	0.000197	CbGpPWpGaD
Dabrafenib—BRAF—Disease—IL6—osteoarthritis	0.000197	0.000197	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—TGFB1—osteoarthritis	0.000183	0.000183	CbGpPWpGaD
Dabrafenib—ABCG2—Metabolism—PTGS2—osteoarthritis	0.000182	0.000182	CbGpPWpGaD
Dabrafenib—RAF1—Disease—TGFB1—osteoarthritis	0.000181	0.000181	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—CXCL8—osteoarthritis	0.00017	0.00017	CbGpPWpGaD
Dabrafenib—RAF1—Signaling by GPCR—IL6—osteoarthritis	0.000161	0.000161	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—MMP9—osteoarthritis	0.000153	0.000153	CbGpPWpGaD
Dabrafenib—RAF1—Immune System—IL6—osteoarthritis	0.000147	0.000147	CbGpPWpGaD
Dabrafenib—BRAF—Signaling Pathways—IL6—osteoarthritis	0.000138	0.000138	CbGpPWpGaD
Dabrafenib—RAF1—Disease—IL6—osteoarthritis	0.000136	0.000136	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—TGFB1—osteoarthritis	0.000126	0.000126	CbGpPWpGaD
Dabrafenib—CYP2C8—Metabolism—PTGS2—osteoarthritis	0.000113	0.000113	CbGpPWpGaD
Dabrafenib—ABCB1—Metabolism—PTGS2—osteoarthritis	9.86e-05	9.86e-05	CbGpPWpGaD
Dabrafenib—RAF1—Signaling Pathways—IL6—osteoarthritis	9.53e-05	9.53e-05	CbGpPWpGaD
Dabrafenib—CYP3A4—Metabolism—PTGS2—osteoarthritis	6.08e-05	6.08e-05	CbGpPWpGaD
